Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet

International Journal of Experimental Pathology

Volumn 92, Issue 6, 2011, Pages 413-421

  Trak Smayra, Viviane ^a   Paradis, Valérie ^b   Massart, Julie ^c   Nasser, Selim ^d   Jebara, Victor ^a   Fromenty, Bernard ^c  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b BEAUJON HOSPITAL   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d Department of Pathology   (Lebanon)

Author keywords

Animal models; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Obese mice

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DIABETES MELLITUS; DIET; FATTY ACID OXIDATION; HIGH CALORY DIET; HISTOPATHOLOGY; INFLAMMATION; LIVER FIBROSIS; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; ENERGY INTAKE; FATTY LIVER; INCIDENCE; LIVER; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED C57BL; NECROSIS; OBESITY; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 82355191481     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2011.00793.x     Document Type: Article

References (42)

1. Anstee Q.M. & Goldin R.D. (2006) Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol. 87, 1-16.
2. Begriche K., Igoudjil A., Pessayre D., Fromenty B. (2006) Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6, 1-28.
3. Begriche K., Lettéron P., Abbey-Toby A. et al. (2008a) Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice. Am. J. Physiol. Endocrinol. Metab. 294, E939-E951.
4. Begriche K., Massart J., Abbey-Toby A. et al. (2008b) β-Aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency. Obesity 16, 2053-2067.
5. Begriche K., Knockaert L., Massart J., Robin M.A., Fromenty B. (2009) Mitochondrial dysfunction in nonalcoholic steatohepatitis (NASH): are there drugs able to improve it? Drug Discov. Today Dis. Mech. 6, e11-e23.
6. Begriche K., Massart J., Robin M.A., Borgne-Sanchez A., Fromenty B. (2011) Drug-induced toxicity on mitochondria and lipid metabolism. Mechanistic diversity and deleterious consequences for the liver. J. Hepatol. 54, 773-794.
7. Bellentani S., Scaglioni F., Marino M., Bedogni G. (2010) Epidemiology of non-alcoholic fatty liver disease. Dig. Dis. 28, 155-161.
8. Bethanis S.K. & Theocharis S.E. (2006) Leptin in the field of hepatic fibrosis: a pivotal or an incidental player? Dig. Dis. Sci. 51, 1685-1696.
9. Carmiel-Haggai M., Cedarbaum A.I., Nieto N. (2005) A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J. 19, 136-138.
10. Cazanave S.C., Mott J.L., Elmi N.A. et al. (2009) JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis. J. Biol. Chem. 284, 26591-26602.
11. Davis R.C., Castellani L.W., Hosseini M. et al. (2010) Early hepatic insulin resistance precedes the onset of diabetes in obese C57BLKS-db/db mice. Diabetes 59, 1616-1625.
12. Dey A. & Cederbaum A.I. (2007) Induction of cytochrome P450 2E1 promotes liver injury in ob/ob mice. Hepatology 45, 1355-1365.
13. Fabbrini E., Sullivan S., Klein S. (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51, 679-689.
14. Farrell G.C. & Larter C.Z. (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43, S99-S112.
15. Fromenty B. & Pessayre D. (1995) Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol. Ther. 67, 101-154.
16. Fromenty B., Vadrot N, Massart J. et al. (2009) Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice. J. Pharmacol. Exp. Ther. 331, 23-34.
17. Garcia-Ruiz I., Rodríguez-Juan C., Díaz-Sanjuán T. et al. (2007) Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice. Hepatology 46, 414-423.
18. Harmancey R., Wilson C.R., Wright N.R., Taegtmeyer H. (2010) Western diet changes cardiac acyl-CoA composition in obese rats: a potential role for hepatic lipogenesis. J. Lipid Res. 51, 1380-1393.
19. Harris R.B., Mitchell T.D., Yan X., Simpson J.S., Redmann S.M. (2001) Metabolic responses to leptin in obese db/db mice are strain dependent. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R115-R132.
20. Iizuka K. & Horikawa Y. (2008) ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocr. J. 55, 617-624.
21. Joshi-Barve S., Barve S.S., Amancherla K. et al. (2007) Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46, 823-830.
22. Kleiner D.E., Brunt E.M., Van Natta M. et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321.
23. Kuwashiro S., Terai S., Oishi T. et al. (2011) Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation. Cell Tissue Res. 344, 125-134.
24. Levene A.P., Kudo H., Thursz M.R., Anstee Q.M., Goldin R.D. (2010) Is oil red-O staining and digital image analysis the gold standard for quantifying steatosis in the liver? Hepatology 51, 1859.
25. Lindström P. (2007) The physiology of obese-hyperglycemic mice [ob/ob mice]. Sci. World J. 7, 666-685.
26. Madiehe A.M., Hebert S., Mitchell T.D., Harris R.B. (2002) Strain-dependent stimulation of growth in leptin-treated obese db/db mice. Endocrinology 143, 3875-3883.
27. Malhi H., Guicciardi M.E., Gores G.J. (2010) Hepatocyte death: a clear and present danger. Physiol. Rev. 90, 1165-1194.
28. Martín-Castillo A., Castells M.T., Adánez G. et al. (2010) Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score inhyperlipidemic chickens. Biomed. Pharmacother. 64, 275-281.
29. Mitchell C., Robin M.A., Mayeuf A. et al. (2009) Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice. Am. J. Pathol. 175, 1929-1937.
30. Osborn O., Sanchez-Alavez M., Brownell S.E. et al. (2010) Metabolic characterization of a mouse deficient in all known leptin receptor isoforms. Cell. Mol. Neurobiol. 30, 23-33.
31. Ota T., Takamura T., Kurita S. et al. (2007) Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology 132, 282-293.
32. Piguet A.C., Stroka D., Zimmermann A. et al. (2009) Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. Clin. Sci. 14, 118.
33. Potter J.J., Rennie-Tankesley L., Mezey E. (2003) Influence of leptin in the development of hepatic fibrosis produced in mice by Schistosoma mansoni infection and by chronic carbon tetrachloride administration. J. Hepatol. 38, 281-288.
34. Rinaldo P., Yoon H.R., Yu C. et al. (1999) Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders. Semin. Perinatol. 23, 204-210.
35. Rinella M.E. & Green R.M. (2004) The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J. Hepatol. 40, 47-51.
36. Rizki G., Arnaboldi L., Gabrielli B. et al. (2006) Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. J. Lipid Res. 47, 2280-2290.
37. Robertson G., Leclercq I., Farrell G.C. (2001) Nonalcoholic steatosis and steatohepatitis II. Cytochrome P-450 enzymes and oxidative stress. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G1135-G1139.
38. Robin M.A., Demeilliers C., Sutton A. et al. (2005) Alcohol increases tumor necrosis factor alpha and decreases NF-κB to activate hepatic apoptosis in genetically obese mice. Hepatology 42, 1280-1290.
39. Sahai A., Malladi P., Pan X. et al. (2004) Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G1035-G1043.
40. Schattenberg JM & Galle PR (2010) Animal models of non-alcoholic steatohepatitis: of mice and man. Dig. Dis. 28, 247-254.
41. 2 emission during long-chain fatty acid oxidation. J. Biol. Chem. 285, 5748-5758.
42. Wang T. & Weinman S.A. (2006) Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C. J. Gastroenterol. Hepatol. 21(Suppl 3), S34-S37.